Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
DiaMedica Therapeutics, Inc. (DMAC) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-8.62M |
|
-- |
|
-- |
|
$9.03M |
|
$-9.03M |
|
$0.42M |
|
$-8.61M |
|
$-8.61M |
|
$-8.62M |
|
$-8.62M |
|
$-8.62M |
|
$-8.62M |
|
$-9.03M |
|
$-9.26M |
|
49.63M |
|
49.63M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$56.22M |
|
$0.15M |
|
$0.82M |
|
$57.05M |
|
$5.27M |
|
$0.01M |
|
$0.16M |
|
$5.42M |
|
$51.62M |
|
$51.62M |
|
$51.62M |
|
52.08M |
|
| Cash Flow Statement Financials | |
$-21.30M |
|
$-10.19M |
|
$31.79M |
|
$3.02M |
|
$3.33M |
|
$0.30M |
|
$2.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.67 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.70% |
|
-16.70% |
|
-15.11% |
|
-16.70% |
|
$0.99 |
|
$-0.43 |
|
$-0.43 |
|